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ABSTRACT: As whole genome sequencing becomes
cheaper and faster, it will progressively substitute tar-
geted next-generation sequencing as standard practice
in research and diagnostics. However, computing cost–
performance ratio is not advancing at an equivalent rate.
Therefore, it is essential to evaluate the robustness of the
variant detection process taking into account the comput-
ing resources required. We have benchmarked six combi-
nations of state-of-the-art read aligners (BWA-MEM and
GEM3) and variant callers (FreeBayes, GATK Haplo-
typeCaller, SAMtools) on whole genome and whole ex-
ome sequencing data from the NA12878 human sample.
Results have been compared between them and against
the NIST Genome in a Bottle (GIAB) variants reference
dataset. We report differences in speed of up to 20 times
in some steps of the process and have observed that SNV,
and to a lesser extent InDel, detection is highly consistent
in 70% of the genome. SNV, and especially InDel, de-
tection is less reliable in 20% of the genome, and almost
unfeasible in the remaining 10%. These findings will aid in
choosing the appropriate tools bearing in mind objectives,
workload, and computing infrastructure available.
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Introduction
As the price of whole exome andwhole genome sequencing (WES
andWGS) has dropped steeply in recent years, there has been amove
within the clinical genetics community towarduseof this technology
in aiding, and confirming, diagnosis, particularly with regards to
rare disease cases. Indeed, WES in particular has been shown to
be effective in solving rare disease cases where initial screening of
panels of candidate genes proved fruitless, with a typical success
rate reported of25% [Yang et al., 2014; Sawyer et al., 2015;Wright
et al., 2015]. Given that this number is only representative of hard-
to-solve cases, it is likely that the real figure, were WES to be used
ab initio for genetic analysis, would be50%–60%, since WES will
identify nearly everything ascertained using a custom panel.
However, there are still some barriers preventing the wide-scale
adoption of this technology in a clinical diagnostic setting [Biesecker
and Green, 2014; Dewey et al., 2014; Goldfeder et al., 2016]. In par-
ticular, WGS is still relatively expensive to sequence and analyze,
though it will progressively substitute targeted sequencing in re-
search and clinical diagnostics over time since it has the added
advantage of allowing better identification of larger chromosomal
events such as structural variants. Sequencing costs have dropped
dramatically in recent years and systems such as the Illumina HiSeq
X-Ten can sequence up to 18,000 human genomes per year at an
advertised cost of $1,000 per genome.However, the computing cost-
performance ratio is not dropping at the same rate, with computing
performance only doubling approximately every 2 years according
to Moore’s law. As few labs have the capability to sequence, process,
store, and interpret these large volumes of data, the optimal choice
of tools and pipelines will impact strongly upon the computing re-
sources required, even for smaller setups. Furthermore, there are
still many parts of the genome that remain difficult to interrogate
correctly using short-read (100–150nt) sequencing because of the
ubiquity of repetitive regions throughout the human genome. WES
on theother hand, althoughmore affordable and requiring less com-
puting resources, suffers somewhat from uneven depth of coverage
of targeted regions due to the target capture and PCR amplification
steps. This means that successful variant detection in such regions
is less assured.
Massively parallel short-read sequencing on Illumina platforms
typically results in the production of 40–400 million reads per
exome or genome, respectively. However, this is just the first step
toward obtaining biologically or medically meaningful results. This
large volume of reads needs to undergo quality control, before be-
ing aligned to a reference genome. These alignments can then be
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interrogated for variant events, that is, positions where the sam-
ple sequenced differs from the reference genome sequence, using a
range of bioinformatics tools, depending on the nature of the event
of interest. As with traditional biology experiments, use of different
tools and parameters at any step may result in different outcomes in
terms of variant events identified. Thus, it is important to be aware
of the qualities, limitations, and any inherent biases of the tools
applied. Furthermore, in the context of large-scale sequencing, the
associated computational costs of analyzing such vast amounts of
raw data must be taken into account.
As a result, there have been initiatives in recent years to assess the
reliability of WGS and WES pipelines [Warden et al., 2014; Zook
et al., 2014; Cornish and Guda, 2015; Highnam et al., 2015; Hwang
et al., 2015], though the majority of benchmarking comparisons
have focused solely onWESdata. As tool development and improve-
ment remains a very active area of research in this field, it is essential
to keep abreast of the latest developments. Here, we detail a bench-
mark of all combinations of two alignment tools, BWA-MEM [Li,
2013], and GEM3 (Marco-Sola et al., manuscript in preparation),
and three popular variant-calling algorithms, FreeBayes [Garrison
and Marth, 2012], GATK HaplotypeCaller [DePristo et al., 2011],
and SAMtools [Li, 2011]. We have used publicly available WGS
data (50×mean coverage) for the HapMap sample NA12878, and
performed WES (90× mean coverage) on DNA from a reference
immortalized cell line from NA12878. All steps of each benchmark
have been run in parallel, using built-in multi-threading options
when supported by the relevant tool, or through running multiple
instances of each tool in parallel on smaller chunks of the input data
when threading is not supported. We provide details of the compu-
tational costs incurred in each step, and compare the accuracy of the
resulting variant calls with a high-confidence whole genome refer-
ence call set for NA12878 compiled by the US National Institute for
Science and Technology (NIST) and the Genome in a bottle (GIAB)
consortium [Zook et al., 2014]. We find substantial differences in
terms of computational costs between tools that have been designed
to perform similar tasks, and some differences in the quality of the
end results in terms of accuracy of variant detection. Furthermore,
we have explored the relationship between the regions defined as
reliably callable by Zook et al. [2014], the regions of the genome
which are potentially uniquely mappable, and the actual coverage
obtained in these regions using BWA-MEM and GEM3. Finally, we
have also studied the concordance of the variants identified by the
three callers in the reliably callable and non-reliably callable regions
of the genome and the exome.
Material and Methods
Source of RawWGS Reads
Reads corresponding to approximately 50× coverage for the
HapMap sample NA12878 were downloaded from the European
Nucleotide archive (www.ebi.ac.uk/ena/data/view/ERP001229).
These FASTQ files, consisting of 101nt read pairs were generated
by Illumina Inc. (Cambridge, UK) on four separate flow cells us-
ing a HiSeq2000 instrument, and released as part of the Platinum
Genomes (http://www.illumina.com/platinumgenomes/).
WES Library Preparation and Sequencing
WESwasperformed at theCentroNacional deAna´lisisGeno´mico
(CNAG-CRG, Barcelona, Spain) using an immortalized cell-line
sample from NA12878, obtained from the collection at NIGMS at
Coriell Institute for Medical Research. Whole exome enrichment
was undertaken with the SeqCap EZMedExome Target Enrichment
Kit (Roche NimbleGen, Madison, WI, US) following the manufac-
turer’s protocol (version 5.1). Pre-capturemultiplexing was applied.
Briefly, 100 ng of genomic DNA was fragmented with CovarisTM
E210 and used for ligation of adapters containing Illumina-specific
indices with a KAPA DNA Library Preparation kit (Kapa Biosys-
tems). Adapter ligated DNA fragments were enriched through nine
cycles of pre-capture PCR using KAPA HiFi HotStart ReadyMix
(2×) (Kapa Biosystems, Wilmington, MA, US) and analyzed on an
Agilent 2100Bioanalyzerwith theDNA7500assay. SampleNA12878
was pre-capture pooled with two other libraries with a combined
mass of 1,250 ng for the bait hybridization step (47ºC, 16 hr). After
washes, themultiplexed captured librarywas recoveredwith capture
beads and amplified with 14 cycles of post-capture PCR using KAPA
HiFi HotStart ReadyMix (2×). Size, concentration, and quality of
the captured material were determined using an Agilent DNA 7500
chip. The success of the enrichment was measured by a qPCR SYBR
Green assay on a Roche LightCycler R© 480 Instrument evaluating
one genomic locus with pre- and post-captured material. The three
library pool was sequenced on an Illumina HiSeq 2000 instrument
in one sequencing lane following the manufacturer’s protocol, with
paired runs of 2 × 101 bp and 2 × 126 bp, to reach a median cov-
erage of 90× for the 46.6 MB target region. Image analysis, base
calling, and quality scoring of the run were performed using Illu-
mina’s Real Time Analysis software (RTA 1.13.48) and generation
of FASTQ files performed by CASAVA.
Alignment and Variant Calling
Raw reads for both WGS and WES were mapped to a version
of the human reference genome, GRCh37, which includes decoy
sequence to improve the efficiency of read-mapping (hs37d5),
as used in the secondary phase of the 1000 genomes project
(ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/phas
e2_reference_assembly_sequence/). For the purposes of bench-
marking alignment algorithm speed, we used a computing node
equipped with 32 hardware threads, whereas for the purpose of
benchmarking variant calling speed, we used a node equipped with
16 hardware threads (Supp. Table S1). We mapped all reads from
each experiment with GEM3, an improved version of the GEM
mapping algorithm [Marco-Sola et al., 2012], and BWA-MEM
version 0.7.8 [Li, 2013]. Following alignment, we sorted the result-
ing BAM files, removed duplicate reads using PICARD (version
1.110; http://broadinstitute.github.io/picard), and performed indel
realignment with GATK (version 3.3) to produce a master BAM for
each experiment-aligner combination (n = 4).
Each master BAM was subsequently used as input to recent ver-
sions of each of three variant calling algorithms, FreeBayes [Garri-
son and Marth, 2012] version 0.9.20, GATK [DePristo et al., 2011]
HaplotypeCaller version 3.3, and SAMtools [Li, 2011] version 1.2.
In the case of SAMtools, we tested two pairs of settings for vari-
ant calling, which we refer to here as normal and fast. The normal
setting includes a probabilistic realignment step for the computa-
tion of base alignment quality, which is disabled in the fast mode.
This step is expected to reduce false positive single nucleotide vari-
ant (SNV) calling due to misalignment. For FreeBayes, we used
default settings for running parallel threads, and for Haplotype-
Caller, we followed the up-to-date version of GATK best practices
pipeline [Van der Auwera et al., 2013], but omitted their final vari-
ant quality score recalibration step (VQSR) for consistency, since a
single WES experiment does not generate enough data for VQSR
to be applicable. For the WES alignments, calling was performed
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as a single process since the quantity of input data is relatively
small, whereas for the WGS samples, calling was separated by chro-
mosome, in order to reduce the elapsed time required for variant
calling.
Raw VCFs output by each of the variant calling pipelines contain
large numbers of false-positive variant calls. Thus, we discarded
any variant positions for which the variant quality score (QUAL)
reported was less than 30 to generate 16 final test call sets—eight
for WGS and eight for WES. By definition, all positions that have
a QUAL score in excess of 30 should have a greater than 99.9%
probability of being a bona fide variant. We recorded elapsed time
and CPU time required for each process to complete, and where a
process was split into chunks, we report the sum of the individual
chunks and the elapsed time required for the largest chunk to com-
plete, since this will be rate-determining. The exact commands used
for all tools for alignment and variant calling are provided in Supp.
Table S2.
Comparison with NIST Reference Variant Call Set
In order to validate the accuracy of SNV and short insertion
and deletion variant (InDel) detection, we downloaded a pub-
licly available set of reference calls for NA12878, generated by
NIST/GIAB through the integration of call sets from a variety of
pipelines [Zook et al., 2014]. To calculate specificity and sensitivity
for each call set, we first compared calls within the 2.2 GB of
the NA12878 genome which Zook et al. [2014] classified as being
reliably callable, that is, excluding genomic regions containing
known copy-number and structural variants and simple repeats
in this sample, which are problematic when mapping short reads
(Supp. Table S3). Subsequently, we calculated mappability statistics
for the whole genome based on paired-end reads with an insert
size of 300nt, allowing for two mismatches with respect to the
reference, using the tool developed by Derrien et al. [2012], and
further investigated the concordance of variant calls made by
the three calling algorithms in the remaining 900 MB of the
genome not included in the NIST reliably callable region. For
WES variant call sets, we restricted the comparison to calls within
the intersection of the NIST reliably callable regions and the
target regions of the NimbleGen exome capture kit, representing
34.7 MB of genomic sequence. As coverage clearly impacts on the
ability to correctly identify variants, we also investigated coverage
in each of these regions using GATK’s DepthOfCoverage tool,
for a variety of minimum depths of coverage, while requiring a
minimum mapping quality of 20 (Supp. Table S2). In order to
normalize VCFs as far as possible, we ran the vcfallelicprimitives
script from the VCFlib suite (https://github.com/vcflib/vcflib) as
recommended by Zook et al. [2014], followed by left-aligning and
trimming variants, with GATK’s LeftAlignAndTrimVariants tool
(https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadin-
stitute_gatk_tools_walkers_variantutils_LeftAlignAndTrimVarian-
ts.php), and used a custom perl script to normalize all genotype
calls to either 0/1, 1/1, or 1/2. As the number of positions that
are multi-allelic for the alternative allele is insignificant (0.15%
in NIST high-confidence set) and full normalization of such
positions is not trivial, we ignored them for this comparison. For
each call set, we identified true positives as positions that were
identical to the NIST reference data set at the level of chromosome,
position, alternative allele observed, and genotype called, false
positives as any call in our variant call sets that was absent from
the NIST set, and false negatives as any call in the NIST set
absent from our call set. Intersecting of datasets was performed
using the BEDtools package [Quinlan, 2014] and Venn diagrams
produced using the VennDiagram R package [Chen & Boutros,
2011].
Results and Discussion
Alignments, Mappability, Coverage, and Callability
Mapping metrics from the alignments generated by BWA-MEM
and GEM3 indicate that they perform quite similarly (Supp. Table
S4). Both tools were able to align over 99%of the reads, independent
of quality, though BWA-MEMmapped a higher proportion of reads
with high quality (i.e., most likely uniquelymapping reads) than did
GEM3 for the WGS but not for the WES sample. This may explain
the higher mismatch rate identified in the BWA-MEMmappings in
only the WGS data. As we would expect, the calculated insert size
(distance between read1 and read2 including the length of the reads)
was also very similar being slightly over 300 bp.
To estimate in which regions of the genome (or exome) it should
be possible to reliably map reads, and confidently identify variants,
we assessed the overlaps between the mappable and reliably callable
regions of the genome and the exome and computed the actual
coverage obtained by BWA-MEM and GEM3 on these regions. Al-
though according to our mappability metrics, 2.8 GB (90.04%)
of the genome should be mappable, the NIST v2.18 dataset defined
only2.2 GB (70.91%) of the genome to be reliably callable (Supp.
Table S5). Unsurprisingly, 99.91% of the reliably callable genome
is mappable but, remarkably, 65.98% of the non-reliably callable
genome is alsomappable.We identified similar trends in the exome,
although the total length of the regions concerned are much shorter
(Supp. Table S6).
Next, we computed the actual coverage on the full genome and on
all combinations of mappable and reliably callable regions (Supp.
Table S7). The overall mean coverage was 49.94 for BWA-MEM and
49.22 for GEM3. In both cases, the mean coverage was around 5%
points higher if computed only on themappable, or only the reliably
callable, regions of the genome. This figure only increased an addi-
tional0.1 if regions which are both mappable and reliably callable
are considered. The non-reliably callable but mappable regions of
the genome had above 50× coverage, whereas the non-mappable
regions of the genome only had a mean coverage of approximately
4×, and the value for the non-reliably callable and non-mappable
regionswas a little lower still. Although thesemetrics were also com-
puted for the exome, results were not so conclusive because of the
short length of the non-mappable region (Supp. Table S8). These
findings indicate that mappability provides a good approximation
of the regions of the genome which will actually be well covered in
the experiment, and also highlights that the definition of reliably
callable used by NIST is particularly stringent.
We also assessed coverage and callability in regions of the med-
ically interpretable genome (MIG), as defined by Patwardhan et
al. [2015], representing a total of 11.7 MB of genome, of which
98.6% is targeted by the MedExome kit. Interestingly, only 78% of
the MIG region is reliably callable according to NIST, suggesting
that there are many medically relevant genes for which short-read
technology may not be sufficient for accurate variant identification.
Nevertheless, our results clearly indicate that the MedExome kit
does a good job of increasing coverage in these specific regions of
interest, as the mean coverage increased to approximately 102×
versus84–88× for the non-MIG regions of theMedExome (Supp.
Table S8), indicating that this kit may be a good option for clinical
applications. Comprehensive coverage and variant calling results on
several samples captured with the MedExome kit will be published
elsewhere.
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Table 1. Summary of Variant Calling for Eight Pipelines for the WGS Sample
Dataset Total calls TP FP FN Specificity Sensitivity F1 score
Whole genome SNVs
NIST v2.18 Gold Standard 2,740,732
BWA-MEM-MEM + FreeBayes 2,744,545 2,738,200 6,345 2,532 0.99769 0.99908 0.99838
BWA-MEM + HaplotypeCaller 2,748,582 2,738,426 10,156 2,306 0.99631 0.99916 0.99773
BWA-MEM + SAMtools fast 2,748,866 2,738,489 10,377 2,243 0.99622 0.99918 0.99770
BWA-MEM + SAMtools normal 2,736,410 2,732,882 3,528 7,850 0.99871 0.99714 0.99792
GEM3 + FreeBayes 2,742,937 2,735,581 7,356 5,151 0.99732 0.99812 0.99772
GEM3 + HaplotypeCaller 2,745,423 2,738,414 7,009 2,318 0.99745 0.99915 0.99830
GEM3 + SAMtools fast 2,749,554 2,736,718 12,836 4,014 0.99533 0.99854 0.99693
GEM3 + SAMtools normal 2,736,871 2,732,313 4,558 8,419 0.99833 0.99693 0.99763
Whole genome deletions
NIST v2.18 Gold Standard 85,958
BWA-MEM + FreeBayes 82,263 75,674 6,589 10,284 0.91990 0.88036 0.89970
BWA-MEM + HaplotypeCaller 86,323 84,789 1,534 1,169 0.98223 0.98640 0.98431
BWA-MEM + SAMtools fast 77,671 68,591 9,080 17,367 0.88310 0.79796 0.83837
BWA-MEM + SAMtools normal 77,712 68,615 9,097 17,343 0.88294 0.79824 0.83846
GEM3 + FreeBayes 81,602 76,002 5,600 9,956 0.93137 0.88418 0.90716
GEM3 + HaplotypeCaller 86,132 84,783 1,349 1,175 0.98434 0.98633 0.98533
GEM3 + SAMtools fast 80,905 69,096 11,809 16,862 0.85404 0.80383 0.82818
GEM3 + SAMtools normal 80,955 69,124 11,831 16,834 0.85386 0.80416 0.82826
Whole genome insertions
NIST v2.18 Gold Standard 84,583
BWA-MEM + FreeBayes 78,592 73,890 4,702 10,693 0.94017 0.87358 0.90565
BWA-MEM + HaplotypeCaller 84,521 83,473 1,048 1,110 0.98760 0.98688 0.98724
BWA-MEM + SAMtools fast 79,762 69,389 10,373 15,194 0.86995 0.82037 0.84443
BWA-MEM + SAMtools normal 79,762 69,396 10,366 15,187 0.87004 0.82045 0.84452
GEM3 + FreeBayes 78,417 73,154 5,263 11,429 0.93288 0.86488 0.89760
GEM3 + HaplotypeCaller 83,973 83,189 784 1,394 0.99066 0.98352 0.98708
GEM3 + SAMtools fast 92,775 71,928 20,847 12,655 0.77530 0.85038 0.81111
GEM3 + SAMtools normal 92,795 71,938 20,857 12,645 0.77524 0.85050 0.81113
TP, true positives; FP, false positives; FN, false negatives; specificity, number of TP calls as a proportion of total calls; sensitivity, number of TP calls as a proportion of the number
of NIST reference set calls; F1-score, measure of overall accuracy calculated as (2 × TP)/((2 × TP) + FP + FN).
Accuracy of Variant Calling
Variant calling results for WGS, split by event type, are shown in
Table 1. Taking the NIST reference set as the ground truth, the num-
bers indicate there is no obvious “best” variant calling pipeline. In
fact all pipelines tested here perform very well, particularly for SNVs
where sensitivity ranged from99.69%to99.92%andspecificity from
99.53% to 99.87% across pipelines, with 99% of SNVs being called
by all three callers (Figs. 1 and 2). InDel events are known to bemore
problematic to align and call consistently [O’Rawe et al., 2013; Fang
et al., 2014, Hasan et al., 2015], and we observe sensitivity ranging
from 79.80% to 98.69%, specificity from 77.52% to 99.07%, and
concordance across all three callers of only 62%–66%. The results
on the exome showed similar trends, with very high sensitivity and
specificity for SNVs and lower for InDels (Supp. Table S9).
Our InDel results are somewhat surprising given that we per-
formed indel realignment equivalently on the aligned BAMs prior
to variant calling, indicating that there are substantial differences
in the manner in which the callers identify InDels. Furthermore,
the difference in total InDel variant calls differs substantially, but
not consistently in direction, depending on the aligner that was
used, suggesting that the underlying representation of InDels in the
raw post-alignment BAMs impacts on variant identification, even
when indel realignment is performed prior to variant calling. In
particular, there is a large difference in the number of InDels iden-
tified by SAMtools for the two WGS alignment datasets, with 16%
more insertions, and 4% more deletions being called in the GEM3
datasets, whereas the difference is less than 1% for FreeBayes and
HaplotypeCaller in each case (Table 1). Notably, the Haplotype-
Caller combinations appear to perform substantially better than
those of the other variant callers in terms of accuracy of InDel
detection. However, this may reflect a bias in the high-confidence
calls in theNIST reference set, which is an integration of 14 different
sequencing platform/aligner/variant caller workflows, but is heav-
ily weighted toward BWA as an aligner (50% of workflows), and
utilized either GATK HaplotypeCaller or GATK UnifiedGenotyper
exclusively for variant identification.
To investigate the InDel observations further, we relaxed the re-
quirement for genotype equivalence when testing for concordance
with the reference set, that is, treating a heterozygote variant call as
equivalent to a homozygote variant call for the same position and al-
ternative allele and vice versa (Supp. Table S10). The overall pattern
of results does not change, but the non-HaplotypeCaller combina-
tions improve somewhat, in particular in the case of FreeBayeswhere
there is a substantial reduction in the number of false-positive and
false-negative InDel calls. This may suggest that FreeBayes’ InDel
calling could be improved slightly.
We observe negligible differences in terms of InDel calls between
the two modes of SAMtools tested, but for SNVs the normal mode
is more specific but less sensitive than the fast mode. This reduction
is sensitivity can be explained in part by a reduction of 0.5% in
the total number of SNVs called when using the normal mode,
in accordance with the stated objective of reducing the number of
false positive SNV calls when using the normal setting. If we relax
the requirement for genotype concordance again, the most marked
improvement is the degree of reduction in false negatives in the fast
mode (Supp. Table S10). This indicates that SAMtools fast-mode
identifies many of the same SNV variant positions as the normal
mode, but differs in the genotype it assigns.
Since one of the major advantages of performing WGS
versus WES is the ability to detect copy-number (CNV) and
structural variants (SV), and as GEM3 has been recently
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Figure 1. Venn diagrams illustrating concordance of variant identification for BWA-MEMalignments. Separate Venn diagrams show the number
and percentage of concordant calls for a particular variant type by pipeline for the NIST reliably callable regions, the NIST non-reliably callable
but mappable regions, and the NIST non-reliably callable regions. SNVs, single nucleotide variants; Dels, deletions; Ins, insertions.
released, we ran Control-FREEC [Boeva et al, 2012] and
DELLY2 [Rausch et al, 2012] on the GEM3 and BWA-MEM
alignments to evaluate CNV and SV detection, respectively.
Using the recommended settings provided by the developers
(http://bioinfo-out.curie.fr/projects/freec/src/config.txt), Control-
FREEC identified exactly the same three significantly likely CNV
events (two losses, and one gain), in each alignment. Furthermore,
when the alignments were processed as a pseudo tumor–normal
pair, no significant events were observed, indicating that there is
no significant bias in normalized coverage between the alignment
datasets (Supp. Table S11). DELLY2 identified a large number
of putative SVs, including large deletions, duplications, and
inversions, but no large insertions events (Supp. Table S12). The
concordance of events varied between 0.37 and 0.86 depending on
the type of event with deletions showing the highest concordance,
followed by inversions and duplications. Although more events of
each type were identified for the BWA-MEM alignments, in the
absence of a reference data set for SVs in this sample, it is impossible
to establish how reliable the calls are, and whether one aligner is
outperforming the other in terms of sensitivity and/or specificity.
The NIST/GIAB consortium are actively working on developing
reference call sets for CNVs and SVs in this sample (Justin Zook,
personal communication), and it will be interesting to compare our
findings with their reference call sets when they become available.
Concordance of Variant Calling Outwith NIST Reliably
Callable Regions
It is not possible to establish the accuracy of variant calls outside
the regions defined as reliably callable in the NIST v2.18 dataset
because there are no reference calls available and, even if there were,
they could not be taken as the “truth.” Therefore, we assessed the
agreement of the different callers by comparing the concordance of
calls in the NIST reliably callable region, the non-reliably callable
region and in the non-reliably callable but mappable region (Figs.
1 and 2; Supp. Table S7). The percentage of each of these genomic
regions covered by at least 10 reads (C10 in Supp. Table S7)
was approximately 100, 66, and 96, respectively. Virtually all of
the reliably callable region is mappable but the reverse is not true.
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Figure 2. Venn diagrams illustrating concordance of variant identification for GEM3 alignments. Separate Venn diagrams show the number and
percentage of concordant calls for a particular variant type by pipeline for the NIST reliably callable regions, the NIST non-reliably callable but
mappable regions, and the NIST non-reliably callable regions. SNVs, single nucleotide variants; Dels, deletions; Ins, insertions.
Surprisingly, the concordance of results in the non-reliably callable
region and in the non-reliably callable but mappable regions is
very similar, though slightly better in the latter. In both cases, the
three callers are concordant for over 75% of the SNVs, but only
30% of the insertions and deletions identified. This illustrates that
mappability and reliably callable are not directly interchangeable.
As mappability is assessed on the reference genome, and reliably
callable regions were identified in a specific sample, with totally
independent methods, it also indicates that there might be some
features of certain genomic regions that make variant calling
difficult even when it is possible to map to them uniquely, and/or
that there may be sample specific limitations. These analyses could
be further stratified in the future with the aim of expanding the
reliably callable region of the genome.
Comparison of WGS and WES Variant Calls
The NA12878 WGS and WES datasets were generated at least
3 years apart by twodifferent labs fromtwodifferent sample aliquots.
Nevertheless, we investigated the concordance of calls between the
WES and WGS data for the GEM3 pipelines, restricting the region
of interest to the 34.7 MB of exome capture region which NIST de-
fined as reliably callable (Fig. 3). This region has excellent coverage
in both WES and WGS data (C10 of 99.43 and 99.99, respectively;
Supp. Tables S7and S8) and we observe an extremely high agree-
ment between SNV calls (98.03%–99.46%). However, there is less
concordance in InDel calls (65.76%–84.85%), with more events be-
ing identified in the MedExomeWES data in general (the exception
being FreeBayes insertions). Fang et al. [2014] reported only 52%
concordance in a similar analysis using an older NimbleGen cap-
ture kit, and found that only 57% of WES-specific InDels could be
validated, whereas 84% of the WGS-specific events tested were vali-
dated using an IlluminaMiSeq. Thus, it is possible that the excess in
InDel calls obtained with the MedExome might be false-positives,
as we have observed a similar trend for this particular kit in an
inter-exome comparison benchmark (manuscript in preparation).
In addition, we observed a particularly large fraction ofWES specific
InDel calls in the HaplotypeCaller call set, the explanation of which
will require further investigation. Overall, and even with the lower
InDel concordance, this WGS and WES comparison indicates that
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Figure 3. Venn diagrams illustrating concordance of WGS and WES variant identification. Separate Venn diagrams show the number and
percentage of concordant calls for a particular variant type for the GEM3 pipelines for variants identified in the intersection of the NIST reliably
callable region and exome capture regions (34.7 MB). SNVs, single nucleotide variants.
Illumina NGS technology and the bioinformatics pipelines tested
here are currently very consistent in their identification of germline
variants. This is in contrast to recent work by Alioto et al. [2015],
which reportedmuch lower concordance in somaticmutationdetec-
tion between different laboratories. They found that large variation
in the quality of library construction would affect downstream re-
sults, especially for protocols using PCR. They also advocate the use
of a combination of somatic mutation callers, in order to identify
somatic mutations, as this improved accuracy of variant detection.
Computational Costs
Computational costs are an important consideration inNGSanal-
yses, since many of the tools involved have significant resource re-
quirements, or can workmore efficiently when provided with access
to more resources. Here, we considered primarily elapsed time (also
known as wall-clock time) in minutes and processing-time (“CPU
time”). As opposed to the actual time taken to complete a task
(i.e., elapsed time), for tasks executed in parallel, CPU-time is the
sum of CPU times devoted to the task by each CPU running it. The
difference between the two can be approximately illustrated by the
following toy example. If a task (e.g., alignment of 100million reads
to a reference sequence) can be achieved in 60 min using a single
processor, or 30 min using two processors, then the elapsed time
has been reduced by half using an extra CPU. However, the CPU
time is expected to remain the same (i.e., 60 min in total) in both
cases. Note that in some cases, overheads due to the parallelization
can be added to the CPU time of the parallel executions. Thus, if
speed is of the essence, as may be the case in clinical diagnostics,
then maximizing the number of processors available for a task may
be the best strategy. On the other hand, if we have multiple tasks to
perform, then assigning each task to a distinct CPU may be more
efficient. It should also be noted that many programs used in ge-
nomics do not scale linearly with the number of CPU used, and will
tend toward an asymptote due to input/output operations, ineffi-
cient parallelization, or RAM becoming limiting factors, and can
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Table 2. Elapsed and CPU Times (Minutes), and Maximum RAM (GB) Requirements for Alignment Algorithms
Exome Genome
BWA-MEM GEM3 BWA-MEM GEM3
Total Largest Chunk Total Largest Chunk Total Largest Chunk Total Largest Chunk
Elapsed time 16 7 6 2.5 570 149 120 31
CPU time 468 192 162 66 17,706 4,633 3,458 904
Max RAM 7.6 15.4 8.3 15.7
Alignment was performed on a compute node that allowed for up to 32 processing threads, supported by 256 GB of available RAM. Elapsed time is the real time required for
the process to complete, whereas CPU time is the sum of the times that CPU threads were actively processing. Exome data came from 3 FASTQ files, whereas WGS came from 4
FASTQ files, the reads of which were mapped independently. The largest chunk time is the maximum time required for mapping of the largest individual chunk of a particular
dataset.
even start to become less efficient when divided into toomany small
tasks.
Here, we observe that the GEM3 mapping algorithm is substan-
tially faster than BWA-MEM, requiring only 6min to fully map 96.5
million WES reads, and 98 min for 1,708 million WGS reads, using
32 threads, representing just 40% and 20% of the time required by
BWA-MEMrespectively, though exploiting twice asmuchRAM.We
observe that both algorithms make good use of the available CPU
threads, as indicated by the CPU-time being between 26-fold and
31-fold the elapsed time, and thus the differences in CPU time are
similar to those of elapsed time (Table 2).Wehave also tested a newly
developed GPU implementation of GEM3, and found it to reduce
mapping time by at least a further 20% for WGS, essentially be-
coming limited only by input/output operations (Marco-Sola et al.,
manuscript in preparation).
Regarding variant calling, we observe that FreeBayes is much
faster than the other algorithms, requiring 41 min to process the
WES samples, and 155–165 min for the WGS samples (Table 3).
SAMtools requires approximately 200 min for the WES samples
and between 3,045 and 3,559 min for the WGS, whereas Haplo-
typeCaller requires between 269 and 362 min for the WES samples,
and between 2,155 and 3,559 min for the WGS samples. FreeBayes
achieves this significant reduction through efficient parallelization
of the variant calling task, making better use of the available hard-
ware threads as clearly shown by the fact that the CPU time for
FreeBayes is 12-fold greater than the elapsed time, whereas the
equivalent value is between threefold and fivefold for GATK, and
just onefold for SAMtools. As SAMtools and HaplotypeCaller are
less able to exploit the availability of multiple CPUs per task, it is
more efficient when using these algorithms to separate large tasks
into smaller individual tasks. Thus, in order to reduce the elapsed
time required for whole genome variant calling by SAMtools and
HaplotypeCaller, we split calling into chromosome-level of chunks.
This resulted in a reduction in the elapsed time required by an order
of magnitude, whereas the CPU time remains constant. Since chro-
mosome 1 is the longest chromosome, it is typically that for which
variant calling takes the longest, and thus provides an upper bound
for time required to variant call a WGS sample, without applying a
more complicated scatter-gather approach. Nevertheless, with the
exception of SAMtools fast mode, the time required to call variants
on chromosome 1 was still longer than that required by FreeBayes
to complete calling on the whole genome, and FreeBayes remained
the most efficient caller in terms of CPU time without the need for
splitting by chromosome.
It should be further noted that the timings for HaplotypeCaller
do not include those of the base quality score recalibration (BQSR)
step, which is currently recommended in GATK Best Practices and
adds a large overhead of approximately an extra hour to the WES
variant calling, and 12 hr for WGS variant calling (100 min for
chromosome 1). However, Warden et al. [2014] found that BQSR
had a relatively modest effect, only impacting on 2%–4% of variant
calls, and it is possible that BQSR may be of less relevance when the
raw sequencing data is of high quality. Thismay beworthy of further
investigation, given the additional computational burden implied by
this step.While variant calling timings describedherewereproduced
on a single node with 16 available CPUs, it has been shown that scal-
ability ofHaplotypeCaller performance decreasesmarkedly after4
threads are used [Kawalia et al., 2015; Intel Corporation, 2016], and
as SAMtools does not support threading the availability of multiple
CPUs has no effect on performance. Thus, a more resource-efficient
way of using HaplotypeCaller, when the computing resources are
available, is to run by chromosome, requesting four threads apiece
(a total of 100 threads, including mitochondrion), and for SAM-
tools to run by chromosome requesting a single thread for each
(25 threads). In our experience, 5 GB of RAM per CPU is sufficient
for each of these tools when run in this manner.
Concluding Remarks
WithWGS progressively becoming standard practice for research
and diagnostics, it will be essential to process large amounts of
Table 3. Elapsed and CPU Times (Minutes) for Variant Calling
BWA-MEM Exome GEM3 Exome BWA-MEMWGS GEM3WGS
Total elapsed
time
CPU time Total elapsed
time
CPU time Total elapsed
time
Largest chunk
elapsed time
CPU time Total elapsed
time
Largest chunk
elapsed time
CPU time
FreeBayes 45 558 41 497 155 N/A 2,104 165 N/A 2,156
HaplotypeCaller 362 1,119 269 1,284 2,155 241 7,930 2,681 238 8,231
SAMtools normal 199 201 211 213 3,045 250 3,025 3,559 334 3,537
SAMtools fast 103 104 114 116 1,328 117 1,309 1,610 139 1,591
Elapsed time is the real time required for the process to complete, whereas CPU time is the sum of the times that CPU threads were actively processing. For exome samples, variant
calls were generated in a single process, whereas for WGS samples variant calling was performed on each chromosome independently, except in the case of FreeBayes which was
sufficiently fast that separating into chunks was unnecessary.
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samples with very high accuracy, in the shortest turnaround time
possible, using theminimumpossible resources.Here,wehave com-
pared tools that are well-established, and frequently used in the
genomics field, but interesting new tools are constantly being devel-
oped [Kelly et al, 2015], and established tools may also be improved
upon [Kathiresan et al, 2014], in this rapidly advancing field. The
high concordance of results obtained between the WGS and WES
data generated by different labs, in different years, from different
aliquots of the NA12878 reference sample, indicates that Illumina
NGS technology and protocols have reached an impressive mature
state. Regardless of the differences observed in run times for the
tools tested, our results show that germline SNV detection is a very
reliable process in 70% of the genome. The InDel results on this
70% of the genome are less impressive, partly because of the tech-
nical difficulty of identifying these variants, and partly because of
the likely bias toward a particular combination of aligner and caller
in generation of the reference data set. Nevertheless, the pipeline
combinations involving HaplotypeCaller and FreeBayes achieved
accuracy in excess of 90% for InDels if we allow for genotype dis-
cordance. Furthermore, variants, especially SNVs, can still be quite
reliably called in an additional 20% of the genome. Further studies
and germline reference data sets will help to estimate the accuracy
of the aligning and variant callings tools on these regions with the
aim of increasing the reliably callable percentage of the genome. For
the remaining 10% of the genome, it seems unfeasible to con-
duct variant calling exercises with the sequencing technology and
tools assayed in this benchmark. The development of new technolo-
gies and tools, in particular long-read sequencing and alignment,
should help to shed some light on these remaining dark regions of
the genome.
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